These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 2442937

  • 1. Arotinoid ethyl ester (Ro 13-6298): a long term pilot study in various dermatoses.
    Mérot Y, Camenzind M, Geiger JM, Saurat JH.
    Acta Derm Venereol; 1987; 67(3):237-42. PubMed ID: 2442937
    [Abstract] [Full Text] [Related]

  • 2. Antipsoriatic activity of a new synthetic retinoid. The arotinoid RO 13-6298.
    Tsambaos D, Orfanos CE.
    Arch Dermatol; 1983 Sep; 119(9):746-51. PubMed ID: 6614962
    [Abstract] [Full Text] [Related]

  • 3. Arotinoid acid (Ro 13-7410): a pilot study in dermatology.
    Saurat JH, Mérot Y, Borsky M, Abba Z, Hirschel-Scholz S.
    Dermatologica; 1988 Sep; 176(4):191-9. PubMed ID: 3378655
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. New indications and new retinoids.
    Gollnick H.
    Dermatologica; 1987 Sep; 175 Suppl 1():182-95. PubMed ID: 3319725
    [Abstract] [Full Text] [Related]

  • 11. [Retinoid-induced changes of the bones and ligaments].
    Zelger B, Frank R, Kemmler G, Fritsch P.
    Hautarzt; 1990 Oct; 41(10):537-44. PubMed ID: 2258296
    [Abstract] [Full Text] [Related]

  • 12. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 13. Retinoids.
    Roenigk HH.
    Cutis; 1987 Apr; 39(4):301-5. PubMed ID: 3472776
    [Abstract] [Full Text] [Related]

  • 14. [Serum triglycerides and cholesterin in patients with skin diseases during oral treatment with aromatic retinoid (author's transl)].
    Gollnick H, Orfanos CE.
    Z Hautkr; 1981 Sep 15; 56(18):1183-96. PubMed ID: 7293303
    [Abstract] [Full Text] [Related]

  • 15. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D.
    Toxic Rep Ser; 1995 Apr 15; 30():1-G5. PubMed ID: 12209194
    [Abstract] [Full Text] [Related]

  • 16. New retinoids for dermatologic diseases. Uses and toxicity.
    Lowe NJ, David M.
    Dermatol Clin; 1988 Oct 15; 6(4):539-52. PubMed ID: 2976328
    [Abstract] [Full Text] [Related]

  • 17. [Psoriasis therapy with the aromatic retinoid Ro 10-9359 (Tigason)].
    Sönnichsen N, Harnack K, Barth J, Heilmann S, Jäger K, Metz D, Schiller F.
    Z Hautkr; 1983 Sep 01; 58(17):1257-67. PubMed ID: 6636927
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tigason (etretinate) treatment in psoriatic arthritis.
    Ciompi ML, Bazzichi L, Marotta G, Pasero G.
    Int J Tissue React; 1988 Sep 01; 10(1):25-7. PubMed ID: 3397251
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.